Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II, multicentre, randomised, double blind, placebo controlled pilot study to determine proof of efficacy, safety, tolerability and pharmacokinetics of intravesical PSD597 [lidocaine] in the symptomatic management of interstitial cystitis/painful bladder syndrome

Trial Profile

Phase II, multicentre, randomised, double blind, placebo controlled pilot study to determine proof of efficacy, safety, tolerability and pharmacokinetics of intravesical PSD597 [lidocaine] in the symptomatic management of interstitial cystitis/painful bladder syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Mar 2008

At a glance

  • Drugs Lidocaine (Primary)
  • Indications Bladder disorders; Interstitial cystitis; Pain
  • Focus Therapeutic Use
  • Sponsors Plethora Solutions
  • Most Recent Events

    • 10 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top